Erratum: Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
Maria Secrier(University College London), Rebecca C. Fitzgerald(Cancer Research UK), Xiaodun Li(AstraZeneca (Singapore)), Jan Bornschein(John Radcliffe Hospital), Andy G. Lynch(University of St Andrews), Hamza Chettouh(University of Cambridge), Jason Crawte(University of Cambridge), Tim Underwood(Southampton General Hospital), Tsun-Po Yang(University of Cambridge), Anna M. Grabowska(Silesian University of Technology), Simon Tavaré(Ludwig Cancer Research), Paul A. Edwards(University of Cambridge), Núria Galeano-Dalmau(University of Cambridge), Gianmarco Contino(University of Cambridge), Lawrence Bower, Andrew P. Barbour(Princess Alexandra Hospital), Ahmad Miremadi(Addenbrooke's Hospital), Barbara Nutzinger(University of Cambridge), Shona MacRae(Hutchison/MRC Research Centre), Achilleas Achilleos(University of Cambridge), Matthew Eldridge(University of Cambridge), John Saunders(Nottingham University Hospitals NHS Trust), Maria O’Donovan(University of Cambridge), Nicola Grehan(University of Cambridge), Nadeera de Silva(University of Cambridge), Nicola Waddell(QIMR Berghofer Medical Research Institute)
Cited by 7
Related Papers
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
|Gut|2013|1.3k
Oesophageal cancer
|Nature Reviews Disease Primers|2017|1.1k
The Universal Protein Resource (UniProt) in 2010
|HAL (Le Centre pour la Communication Scientifique Directe)|2010|924